Infectious Disease

Prognostic Test Identifies Infants at High-Risk for Severe Respiratory Infection

Dr. Fernando P. Polack, a leading international researcher in pediatric infectious diseases, has discovered a new prognostic to predict which infants are at high-risk for hospitalization caused by severe Respiratory Syncytial Virus (RSV) infections. The test measures a mutation in a single gene, along with a quantifiable environmental factor that confers susceptibility. The goal is to categorize infants most likely to benefit from preventative care.

Mike Villalobos
Read more

Inhibitors of Inward-rectifying potassium channels (insecticide)

This research targets IRK.
Licensing manager: 
Tom Utley
Read more

Luciferase Reporter System for viral detection in vitro and in vivo

This research targets Respiratory Syncytial Virus.
Licensing manager: 
Taylor Jordan
Read more

mouse anti-Clostridium difficile Toxin A monoclonal antibody, c-terminal

This research targets TcdA.
Licensing manager: 
Jody Hankins
Read more

Purified staphylocoagulase fragment (1-325)

  This research targets S. Aureus.
Licensing manager: 
Karen Rufus
Read more

Sterile blood culture collection kit for reducing blood culture contamination at healthcare institutions

Scientists at Vanderbilt have developed a sterile kit to collect blood cultures that results in substantially fewer contaminated cultures compared to the current standard of care for collecting culture specimens.

Summary
Clinicians at Vanderbilt have developed a sterile kit to collect blood cultures that results in substantially fewer contaminated cultures compared to the current standard of care for collecting culture specimens.

Addressed Clinical Need
Blood cultures are performed tens of millions of times annually in the U.S.

Licensing manager: 
Masood Machingal
Read more

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter